A carregar...
COVID-19 in a patient with severe asthma using mepolizumab
BACKGROUND: There is a lack of information about the course of coronavirus disease 2019 (COVID-19) in patients with severe asthma who were treated with biologics. Some reports indicated that treatment with benralizumab, dupilumab, and omalizumab in patients with severe asthma was not associated with...
Na minha lista:
| Publicado no: | Allergy Asthma Proc |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
OceanSide Publications, Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8133013/ https://ncbi.nlm.nih.gov/pubmed/33536114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2500/aap.2021.42.200125 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|